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Sepsis is one of the oldest and most elusive
syndromes in medicine. Every effort should be made
to treat these patients with the best available
evidence. As a milestone, empiric antimicrobial
therapy is essential in order to reduce morbidity and
mortality of septic patients. As a sticking point, the
use of broad-spectrum antimicrobial agents may be
associated with induction of resistance among
common pathogens.Timing of antimicrobial therapy
Rationale for early antibiotic therapy
Worldwide, the annual prevalence of sepsis is estimated
at 19 million cases [1]. The mortality rates in severe
sepsis were reduced to 20% to 30% because of advances
in training, recognition, surveillance, monitoring, and
rapid initial antibiotic therapy and organ support [1,2].
The most recent update of the Surviving Sepsis Campaign
guidelines was published in 2013 [3]. A consensus
committee provided valuable and clear recommendations
on treatment of sepsis and septic shock (Table 1).
One of the main focuses is the administration of a
broad-spectrum antibiotic (Table 2) [3]. It is recommended
that antimicrobials be administrated within the first hour
of recognition of septic shock and severe sepsis without
septic shock [4-7]. Moreover, it is recommended that initial
anti-infective therapy include one or more drugs that have
activity against all likely pathogens and penetrate in
adequate concentrations into the target tissue [3]. The
selected antibiotic strategy should anticipate the site
of infection, medical and culture history, and local
microbial susceptibility results, all in an emergency
situation [1,8].* Correspondence: michael.bernhard@medizin.uni-leipzig.de
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Appropriate antibiotic therapy
In a systematic review and meta-analysis, Paul and
colleagues [9] found a pooled odds ratio of appropriate
antibiotic therapy during the first 48 hours for all-cause
mortality of 1.60 (95% CI 1.37 to 1.86), corresponding to
a number needed to treat of 10 (95% CI 8 to 15). Kumar
and colleagues [4] found a time-dependent mortality with
a 7.6% decrease in survival for each hour of antibiotic
delay in patients with sepsis.Some recently published investigations supported the
findings by Kumar and colleagues [4] (Table 3). Ferrer and
colleagues [10] presented a retrospective analysis of a large
dataset collected prospectively. In total, 28,150 patients
with severe sepsis and septic shock from 165 ICUs in
Europe, the US, and South America were included.
Of them, 17,990 patients received antibiotics after
identification of sepsis, and the in-hospital mortality was
29.7%. After 1 hour, hospital mortality steadily increased
with a delay in antibiotic timing. The adjusted hospital
mortality odds ratios steadily increased from 1.00 to
1.52 as time to antibiotic administration increased
from 0 to greater than 6 hours where 0 to 1 hour
was the reference group. The probability of mortality
increased from 24.6% to 33.1% (P <0.001) [10]. However,
critics stated that, owing to a lack of information on
antibiotic appropriateness and focus control, this study
was limited [1].
In contrast, Puskarich and colleagues [11] reported
results from a large prospective study of emergency
department patients with septic shock, which failed to
demonstrate an association between timing of antibiotic
administration from emergency department triage and
hospital mortality. A delay in antibiotics until after shock
recognition, as compared with before, was associated
with increased mortality; however, if antibiotics are
administered after shock recognition, there is no increase
in mortality with hourly delays. These findings were inal Ltd. The licensee has exclusive rights to distribute this article, in any medium,
this time, the article is available under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Extract of the key recommendations and
suggestions of the Surviving Sepsis Campaign guidelines [3]
● Early quantitative resuscitation of the septic patient during the first
6 hours after recognition (1C)
● Blood cultures before antibiotic therapy (1C)
● Imaging studies performed promptly to confirm a potential source
of infection (UG)
● Administration of broad-spectrum antimicrobials therapy within 1
hour of the recognition of septic shock (1B) and severe sepsis
without septic shock (1C) as the goal of therapy
● Reassessment of antimicrobial therapy daily for de-escalation, when
appropriate (1B)
● Infection source control with attention to the balance of risks and
benefits of the chosen method within 12 hours of diagnosis (1C)
Principles of the Grading of the Recommendations Assessment, Development,
and Evaluation (GRADE) system to guide assessment of quality of evidence
from high (A) to very low (D) and to determine the strength of
recommendations as strong (1) or weak (2). UG, ungraded.
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Ferrer and colleagues [10]. The differences may be
explained by a higher severity of illness in the other
two studies. For example, Kumar and colleagues [4]
investigated ICU patients with septic shock with an
overall mortality of 56% in comparison with the emer-
gency department patients in the study by Puskarich
and colleagues [11] with 19%. With respect to these
findings, the focus on the observed patient cohort
seems to be essential.
In a prospective observational multicenter cohort
study in 44 German ICUs including 1,011 patients with
severe sepsis and septic shock, Bloos and colleagues
[12] did not find a linear association between timing
of antibiotic therapy and 28-day mortality. However,
regardless of timing, 28-day mortality rate was lower
in patients with adequate antibiotic therapy than in
those with non-adequate antibiotic therapy (30% versus
41%, P <0.001). Bloos and colleagues stated that, owing
to differences in the related patient populations, they
were not able to confirm the findings of Kumar and
colleagues [4].
Given these findings, the concept of early empiric anti-
biotic therapy has recently been challenged. More and
more, the underlying and treated patient population has
come into focus.Table 2 Extract from the Surviving Sepsis Care bundles [3]
To be completed within 3 hours
1. Measure lactate levels.
2. Obtain blood cultures prior to administration of antibiotics.
3. Administer broad-spectrum antibiotics.
4. Administer 30 mL/kg crystalloid for hypotension of lactate of at least
4 mmol/L.Escalating versus de-escalating strategy
With respect to the previously reported investigations,
Hranjec and colleagues [13] presented data from a 2-year,
quasi-experimental before-and-after observational study
of hemodynamically stable patients admitted to a surgical
ICU. In the first year, patients suspected of having an
infection (n =101, aggressive approach, de-escalating
strategy) had blood cultures and antimicrobial therapy
was started. In the second year, patients suspected of
having an infection (n =100, conservative approach,
escalating strategy) had an antimicrobial therapy only
after objective findings confirmed an infection. The
conservative approach was associated with lower all-cause
mortality: (13/100) 13% versus (27/101) 27%, P =0.015.
The odds ratio for the risk of mortality in the aggressive
approach group was 2.5 (95% CI 1.5 to 4.0) in comparison
with the conservative group. In this investigation, waiting
for objective data to diagnose infection before treatment
with antimicrobial agents for suspected infection does not
worsen the mortality.
Conclusions
Early broad-spectrum antimicrobial therapy is necessary
within the ‘golden hour’ in septic shock and, as a milestone,
reduces mortality. However, the use of broad-spectrum
antimicrobial agents may be associated with induction of
resistance among common pathogens and therefore
may be a sticking point. In septic patients without
sepsis-associated hypotension, diagnostic measure
may be beneficial before an antibiotic therapy starts.
New research is urgently needed concerning different
strategies that would balance early administration of
antibiotics against the potential harmful effects to
patients and resistance. New research strategies have to
test a de-escalating strategy with restriction of specific
broad-spectrum antibiotics in the initial therapy to the
most critically ill patients and patients with suspicion of
multidrug-resistant pathogens, against an escalating
strategy in less critically ill patients. Moreover, further
studies are needed to distinguish between more and less
critically ill patients, to differentiate patients’ backgrounds,
and to determine indicators for patients who profit from
an escalating or de-escalating strategy.
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Table 3 Comparison of studies investigating antibiotic treatment in patients with sepsis
Parameter Kumar et al. [4] Crit
Care Med (2006)
Ferrer et al. [10] Crit Care Med (2014) Puskarich et al. [11]
Crit Care Med (2011)
Bloos et al. [12]
Crit Care (2014)
Hranjec et al. [13] Lancet
Infect Dis (2012)
Study design Retrospective multicenter
cohort study
Retrospective analysis of prospective
collected dataset multicenter
Prospective preplanned analysis of a






Setting ICU septic shock ICU mixed ED septic shock ICU ICU-acquired infection
Aggressive Conservative
Patients 2,731 17,993 291 1,011 247 237
Age, years 63 NR 62 (IQR 50–73) 69 NR NR
Gender, male 54% NR 53% 63% NR NR
APACHE score 26 ± 9 NR NR NR NR NR
SAPS II NR NR 42 (IQR 30–55) 48 (IQR 37–60) NR NR
SOFA score NR NR 6 (IQR 4–9) 10 (IQR 8–12) NR NR
MEDS score NR NR 11 (IQR 8–14) NR NR NR
Septic shock 2,731 (100%) 11,558 (64.2%) 291 (100%) NR 38.5% 46.4%
Positive BC 34.2% NR 100 (34.4%) 317 (48.8%) NR NR
Nosocomial 58.1% 12.2% NR 56.2% NR NR
Median time to
shock recognition
NR NR 89 (IQR 48–180) NR NR NR








NR NR 29/191 (15.2%) NR NR NR
Infection site
Pneumonia 1,016 (37.2%) 8,487 (47.2%) 99 (34.0%) 351 (34.9%) 75 (20%) 93 (39%)
UTI 293 (10.7%) 4,757 (26.4%) 71 (24.4%) 122 (12.1%) 33 (13%) 36 (15%)
Intra-abdominal 801 (29.3%) 3,505 (19.5%) 49 (16.8%) 366 (36.3%) 31 (13%) 22 (9%)
Skin and soft tissue 197 (7.2%) 1,133 (6.3%) 23 (7.9%) NR NR NR
Intravascular catheter 100 (3.7%) 661 (3.7%) 11 (3.8%) NR 14 (6%) 8 (3%)
Surgical wounds 31 (1.1%) 815 (4.5%) 7 (2.4%) NR 19 (8%) 21 (9%)
Endocarditis NR 187 (1.0%) 4 (1.4%) NR NR NR
CNSI (e.g., meningitis) 20 (0.7%) 277 (15%) 3 (1.0%) NR NR NR
Septic arthritis 21 (0.8%) NR 2 (0.7%) NR NR NR












Table 3 Comparison of studies investigating antibiotic treatment in patients with sepsis (Continued)
Ear, nose, throat NR NR 1 (0.3%) NR NR NR
Toxic shock syndrome NR NR 1 (0.3%) NR NR NR
Unknown 120 (4.4%) NR 40 (13.8%) 50 (5%) 49 (20%) 46 (19%)
Two or more sources NR NR 21 (7.2%) NR NR NR
Mediastinitis 15 (0.5%) NR NR NR NR NR
Other 59 (2.1%) 1,980 (11.0%) NR 105 (10.4%) 26 (11%) 11 (5%)
Bone NR 232 (1.3%) NR NR NR NR
Device NR 219 (1.2%) NR NR NR NR
Bone/soft tissue NR NR NR 72 (7.1%) NR NR
Upper airway NR NR NR 83 (8.2%) NR NR
APACHE, Acute Physiology and Chronic Health Evaluation; BC, blood culture; CNSI, central nervous system infection; ED, emergency department; IQR, interquartile range; MEDS, Mortality in Emergency Department
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